214 related articles for article (PubMed ID: 11001907)
1. Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparin-binding proteins.
Børset M; Hjertner O; Yaccoby S; Epstein J; Sanderson RD
Blood; 2000 Oct; 96(7):2528-36. PubMed ID: 11001907
[TBL] [Abstract][Full Text] [Related]
2. Heparan sulfate regulates targeting of syndecan-1 to a functional domain on the cell surface.
Yang Y; Børset M; Langford JK; Sanderson RD
J Biol Chem; 2003 Apr; 278(15):12888-93. PubMed ID: 12566461
[TBL] [Abstract][Full Text] [Related]
3. High levels of soluble syndecan-1 in myeloma-derived bone marrow: modulation of hepatocyte growth factor activity.
Seidel C; Børset M; Hjertner O; Cao D; Abildgaard N; Hjorth-Hansen H; Sanderson RD; Waage A; Sundan A
Blood; 2000 Nov; 96(9):3139-46. PubMed ID: 11049995
[TBL] [Abstract][Full Text] [Related]
4. Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma.
Derksen PW; Keehnen RM; Evers LM; van Oers MH; Spaargaren M; Pals ST
Blood; 2002 Feb; 99(4):1405-10. PubMed ID: 11830493
[TBL] [Abstract][Full Text] [Related]
5. Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen.
Ridley RC; Xiao H; Hata H; Woodliff J; Epstein J; Sanderson RD
Blood; 1993 Feb; 81(3):767-74. PubMed ID: 8427968
[TBL] [Abstract][Full Text] [Related]
6. Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions.
Bayer-Garner IB; Sanderson RD; Dhodapkar MV; Owens RB; Wilson CS
Mod Pathol; 2001 Oct; 14(10):1052-8. PubMed ID: 11598177
[TBL] [Abstract][Full Text] [Related]
7. Soluble syndecan-1 promotes growth of myeloma tumors in vivo.
Yang Y; Yaccoby S; Liu W; Langford JK; Pumphrey CY; Theus A; Epstein J; Sanderson RD
Blood; 2002 Jul; 100(2):610-7. PubMed ID: 12091355
[TBL] [Abstract][Full Text] [Related]
8. Syndecan-1 in B lymphoid malignancies.
Sanderson RD; Børset M
Ann Hematol; 2002 Mar; 81(3):125-35. PubMed ID: 11904737
[TBL] [Abstract][Full Text] [Related]
9. Syndecan-1 is a multifunctional regulator of myeloma pathobiology: control of tumor cell survival, growth, and bone cell differentiation.
Dhodapkar MV; Abe E; Theus A; Lacy M; Langford JK; Barlogie B; Sanderson RD
Blood; 1998 Apr; 91(8):2679-88. PubMed ID: 9531576
[TBL] [Abstract][Full Text] [Related]
10. Syndecan-1 (CD 138) in myeloma and lymphoid malignancies: a multifunctional regulator of cell behavior within the tumor microenvironment.
Dhodapkar MV; Sanderson RD
Leuk Lymphoma; 1999 Jun; 34(1-2):35-43. PubMed ID: 10350330
[TBL] [Abstract][Full Text] [Related]
11. Heparan sulfate-mediated cell aggregation. Syndecans-1 and -4 mediate intercellular adhesion following their transfection into human B lymphoid cells.
Stanley MJ; Liebersbach BF; Liu W; Anhalt DJ; Sanderson RD
J Biol Chem; 1995 Mar; 270(10):5077-83. PubMed ID: 7890615
[TBL] [Abstract][Full Text] [Related]
12. Evidence of a role for a non-matrix-type metalloproteinase activity in the shedding of syndecan-1 from human myeloma cells.
Holen I; Drury NL; Hargreaves PG; Croucher PI
Br J Haematol; 2001 Aug; 114(2):414-21. PubMed ID: 11529866
[TBL] [Abstract][Full Text] [Related]
13. Moesin interacts with the cytoplasmic region of intercellular adhesion molecule-3 and is redistributed to the uropod of T lymphocytes during cell polarization.
Serrador JM; Alonso-Lebrero JL; del Pozo MA; Furthmayr H; Schwartz-Albiez R; Calvo J; Lozano F; Sánchez-Madrid F
J Cell Biol; 1997 Sep; 138(6):1409-23. PubMed ID: 9298994
[TBL] [Abstract][Full Text] [Related]
14. [The expression, secretion and regulation of membrane-soluble syndecan-1 in human multiple myeloma cells].
Li X; Lu Z; Klein B
Zhonghua Xue Ye Xue Za Zhi; 2000 Nov; 21(11):572-6. PubMed ID: 11225246
[TBL] [Abstract][Full Text] [Related]
15. Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation.
Subramanian SV; Fitzgerald ML; Bernfield M
J Biol Chem; 1997 Jun; 272(23):14713-20. PubMed ID: 9169435
[TBL] [Abstract][Full Text] [Related]
16. Syndecan-1 mediates cell spreading in transfected human lymphoblastoid (Raji) cells.
Lebakken CS; Rapraeger AC
J Cell Biol; 1996 Mar; 132(6):1209-21. PubMed ID: 8601596
[TBL] [Abstract][Full Text] [Related]
17. Syndecan-1-dependent homotypic cell adhesion in HT58 lymphoma cells.
Sebestyén A; Tótth A; Mihalik R; Szakács O; Paku S; Kopper L
Tumour Biol; 2000; 21(6):349-57. PubMed ID: 11006575
[TBL] [Abstract][Full Text] [Related]
18. Syndecan-2 expression in colorectal cancer-derived HT-29 M6 epithelial cells induces a migratory phenotype.
Contreras HR; Fabre M; Granés F; Casaroli-Marano R; Rocamora N; Herreros AG; Reina M; Vilaró S
Biochem Biophys Res Commun; 2001 Aug; 286(4):742-51. PubMed ID: 11520060
[TBL] [Abstract][Full Text] [Related]
19. Syndecan-1 transmembrane and extracellular domains have unique and distinct roles in cell spreading.
McQuade KJ; Rapraeger AC
J Biol Chem; 2003 Nov; 278(47):46607-15. PubMed ID: 12975379
[TBL] [Abstract][Full Text] [Related]
20. Adhesion of B lymphoid (MPC-11) cells to type I collagen is mediated by integral membrane proteoglycan, syndecan.
Sanderson RD; Sneed TB; Young LA; Sullivan GL; Lander AD
J Immunol; 1992 Jun; 148(12):3902-11. PubMed ID: 1602136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
